Recent Posts
- DPP4 inhibitors for type 2 diabetes found not to raise angioedema risk
- FDA OKs sebetralstat, now Ekterly, as oral on-demand HAE therapy
- ACE inhibitor deemed cause of woman’s intestinal angioedema
- Pendopharm, Kalvista to bring sebetralstat for HAE to Canada
- Voices for change in a village of rare disease advocates, part 3